A detailed history of Inter Ocean Capital Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Inter Ocean Capital Group, LLC holds 1,749 shares of VRTX stock, worth $713,906. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,749
Previous 1,372 27.48%
Holding current value
$713,906
Previous $558,000 31.0%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $153,699 - $168,172
377 Added 27.48%
1,749 $731,000
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $470,596 - $563,452
1,372 New
1,372 $558,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Inter Ocean Capital Group, LLC Portfolio

Follow Inter Ocean Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inter Ocean Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inter Ocean Capital Group, LLC with notifications on news.